Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products

SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Cision PR Newswire

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture...
Cision PR Newswire

Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List

PALO ALTO, Calif. and SUZHOU, China, Nov. 14, 2026 /PRNewswire/ -- Innovent Biologics, Inc....
Cision PR Newswire

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

gtinfetch.ai, WeFetch.ai's lead product, removes the guess from artificial intelligence (AI) shopping: the right...
Cision PR Newswire

GIBO Advances Toward Integrated Autonomous Mobility Systems, Building a Unified AI Stack Across Air and Ground Platforms

KUALA...

AI/works™ heralds a new era of Agile and next-generation software development

Thoughtworks'...

Infosys is the Fastest Growing IT Services Brand Globally with a CAGR of 15% in Brand Value

Top...

Fushi Tech and Commonwealth Concepts Singapore Partner to Launch Integrated One-Stop Digital Platform for F&B Excellence

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- Fushi Tech, a global provider of integrated AI & digital solutions for merchants, today announced a strategic partnership...

Nuvoton Releases High-Power Ultraviolet Laser Diode (379 nm, 1.0 W)

KYOTO, Japan, Jan. 20, 2026 /PRNewswire/ -- Nuvoton Technology Corporation Japan (hereinafter "NTCJ") announced on January 20 the start of mass production of its...

Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology

DAEJEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with...
1...1,4651,4661,467...4,530Page 1,466 of 4,530